The level of cytokines in tears as a novel indicator of demyelinating diseases
- 11 April 2024
- journal article
- research article
- Published by Taylor & Francis in Neurological Research
- Vol. 46 (6) , 487-494
Abstract
A novel research objective is to identify new molecules in more readily accessible biological fluids that could be used in the diagnosis of multiple sclerosis (MS) and other demyelinating disorders. To compare the level of selected cytokines in tears between patients with MS or other demyelinating disorder and healthy controls. 84 patients with diagnosed MS during remission or with other demyelinating disease of the CNS and 70 healthy controls were enrolled in the study. Tears were collected without any stimulation and stored till the day of assessment. The concentration of selected cytokines was measured by the Bio-Plex Pro Human cytokine screening panel 27 cytokines assay according to the manufacturer's instructions. Statistical analysis was performed with Statistica 13. IL-1b level was significantly lower in the study group compared to the control group [3,6 vs 8.71, p < 0.001]. The same pattern was observed for IL-6 [3,1 vs 5.26, p = 0.027] and IL-10 [1,7 vs 10.92, p < 0.001] (Table 1). In the study group, IL-1RA (p = 0.015), IL-5 (p = 0.04), IL-9 (p = 0.014), and IL-15 (p = 0.037) showed significant correlations with age. In the total sample, IL-1Ra (p = 0.016) and IFN-g (p = 0.041) were significantly correlated with age, while in the control group, IL-8 (p = 0.09), MIP-1a (p = 0.009), and RANTES (p = 0.031) showed significant correlations. Our results show that MS and other demyelination diseases lead to decrease in the overall level of cytokines in tears. Further research is needed to determine the role of tear fluid in the assessment of demyelinating disorders like MS.Keywords
Funding Information
- Medical University of Silesia (PCN-2-100/N/1/K)
This publication has 40 references indexed in Scilit:
- Th17 cytokines and factors modulating their activity in patients with pernicious anemiaImmunologic Research, 2023
- Dry eye syndrome: comprehensive etiologies and recent clinical trialsInternational Ophthalmology, 2022
- Biochemistry of human tear film: A reviewExperimental Eye Research, 2022
- Mass spectrometry‐based tear proteomics for noninvasive biomarker discoveryMass Spectrometry Reviews, 2021
- Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patientsExperimental Eye Research, 2020
- The Properties of Cytokines in Multiple Sclerosis: Pros and ConsThe American Journal of the Medical Sciences, 2018
- Molecular biomarkers in primary open-angle glaucoma2015
- Unraveling the molecular repertoire of tears as a source of biomarkers: Beyond ocular diseasesProteomics – Clinical Applications, 2014
- Exploring the human tear fluid: Discovery of new biomarkers in multiple sclerosisProteomics – Clinical Applications, 2014
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011